-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, recalling the unveiling moment of the randomized controlled double-blind trial project eight years ago, Professor Huang Congxin, a well-known cardiologist in China, is still full of
"It was August 8, 2014, and every one of us, including academicians, was in a very anxious mood, as researchers, after 582 days of hard work, we all wanted to see a positive result, worried that there would be a negative result.
This experiment can make the country's top cardiology experts and academicians of the Chinese Academy of Engineering so important, because it is a sub-project of the national 973 program, and it is related to the solution
Completed the 973 project and won the highest award of the national life sciences
Professor Huang Congxin is the honorary chairman of the Cardiac Electrophysiology and Pacing Branch of the Chinese Medical Association, the former vice president of Wuhan University, and the director of the Institute of Cardiovascular Diseases of
The project was participated by 31 clinical centers such as Wuhan University People's Hospital and Zhongshan Hospital Affiliated to Fudan University, and 465 patients were included in the study on the basis of standardized treatment of chronic heart failure, the treatment group was given a ginseng song heart capsule, and the control group was given a placebo, and the rate of decline in the number of ventricular premature beats in the 24-hour Holter ECG of the two groups of patients after 3 months was used as the main evaluation index, which lasted 582 days
The results showed that the addition of ginseng pine heart capsules could not only inhibit arrhythmias, reduce the number of 24-hour room early hours in patients, but also improve cardiac function, increase left ventricular ejection fraction, reduce the level of N-terminal brain natriuretic peptide precursors, and also improve the quality of life of
"Heart failure and arrhythmia are a pair of 'brothers and sisters', the two are mutually causal, and the ginseng pine heart capsule can improve heart failure, so it can also improve the arrhythmias caused by heart failure, providing a very good drug choice
On January 10, 2020, Professor Huang Congxin and Academician Wu Yiling stood on the highest podium
Everything speaks with evidence-based medical evidence
The beating of the heart drives the flow of blood and determines the length
Professor Huang Congxin said that as a common clinical cardiovascular disease, the treatment measures for arrhythmias include drug treatment and non-drug treatment
An ideal antiarrhythmic drug needs to meet three conditions at the same time: one is to curb arrhythmias, the other is to reduce arrhythmia mortality, and the third is to reduce all-cause mortality from
In 2012, the clinical research related to the treatment of heart failure with ventricular premature beats was initiated
"It doesn't matter, everything is based on evidence-based medical evidence, and I have no complaints or regrets
Professor Huang Congxin admitted that participating in the project of "the construction of Chinese medicine vein theory and its guidance for the prevention and treatment of microvascular lesions" not only made him appreciate the mysteries of traditional Chinese medicine, but also made him think that the limitations of Western medicine and Western medicine are precisely what Chinese medicine can make up
"Chinese medicine is a treasure in the history of Chinese medicine and should not only make it shine on the land of China, but also push it onto the world-class stage and shine for the construction of a community with a shared future for mankind!" Professor Huang Congxin said
Professor Huang Congxin said that with the rapid development of computer science, information technology and digital technology, the era of digital medicine will eventually replace the era of evidence-based medicine, which can concentrate the data of the whole country and even the world in the data processing center, screen out useful information, and guide the clinic and better benefit